AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28549081 — intervention group
Group type: COMPARATOR
Intervention: Miller direct laryngoscope (DL)
Number of subjects: 200
Study 25854809 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based occupational therapy for 10 weeks
Number of subjects: 191
Study 25854809 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no occupational therapy)
Number of subjects: 191
Study 25476074 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide therapy, anisodamine, nitroglycerin, beta blocker or cedilanid
Number of subjects: 120
Study 22030597 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination treatment (olmesartan medoxomil 40/amlodipine besylate 10/hydrochlorothiazide 25 mg)
Number of subjects: 0
Study 22030597 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination treatment
Number of subjects: 0
Study 22030597 — intervention group
Group type: COMPARATOR
Intervention: Dual-combination treatments
Number of subjects: 0
Study 19387957 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation of AF
Number of subjects: 15
Study 19387957 — intervention group
Group type: COMPARATOR
Intervention: Control group (younger patients)
Number of subjects: 15
Study 17560141 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin
Number of subjects: 4
Study 17560141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 14984936 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole pelvic radiation therapy (RT)
Number of subjects: 392
Study 14984936 — intervention group
Group type: COMPARATOR
Intervention: No additional therapy (NAT)
Number of subjects: 392
Study 12219873 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun PrecisionSensor 2000 with position sensor
Number of subjects: 43
Study 12219873 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun PrecisionSensor 2000 without position sensor
Number of subjects: 43
Study 12219873 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory 24-hour blood pressure measurement (ABPM)
Number of subjects: 43
Study 10402973 — intervention group
Group type: EXPERIMENTAL
Intervention: SPf66 vaccine (three doses at 1, 2, and 7 months of age)
Number of subjects: 1207
Study 10402973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1207
Study 10402973 — intervention group
Group type: EXPERIMENTAL
Intervention: SPf66 vaccine
Number of subjects: 1207
Study 8697925 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 57
Study 8697925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 2694978 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiabendazole 2 x 25 mg kg‐1 day‐1
Number of subjects: 34
Study 2694978 — intervention group
Group type: COMPARATOR
Intervention: Albendazole 2 x 5 mg kg‐1 day‐1
Number of subjects: 34
Study 973982 — intervention group
Group type: EXPERIMENTAL
Intervention: HSA-Tc 99m instilled intranasally as drops
Number of subjects: 11
Study 973982 — intervention group
Group type: COMPARATOR
Intervention: HSA-Tc 99m instilled intranasally as spray
Number of subjects: 11
Study 973982 — intervention group
Group type: EXPERIMENTAL
Intervention: HSA-Tc 99m instilled intranasally (varied volume 0.10 ml to 0.75 ml, concentration 3% to 30%)
Number of subjects: 11
Study 973982 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertechnetate in isotonic saline
Number of subjects: 11
Study 973982 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent administration by drops
Number of subjects: 11
Study 30285186 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Stress Management (CBSM)
Number of subjects: 192
Study 30285186 — intervention group
Group type: COMPARATOR
Intervention: Health Promotion (HP)
Number of subjects: 192
Study 28675091 — intervention group
Group type: EXPERIMENTAL
Intervention: Coffee polyphenols (CPPs) 270 mg/100 mL/day
Number of subjects: 49
Study 28675091 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 49
Study 24965855 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive water-based exercise (Cog-WE)
Number of subjects: 21
Study 24965855 — intervention group
Group type: COMPARATOR
Intervention: Normal water-based exercise (Nor-WE)
Number of subjects: 21
Study 23777672 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling intervention aimed at adopting healthy lifestyle behaviors
Number of subjects: 622
Study 23777672 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving health brochures
Number of subjects: 622
Study 23777672 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling intervention for participants who finished secondary school
Number of subjects: 622
Study 23777672 — intervention group
Group type: COMPARATOR
Intervention: Control group for participants who finished secondary school
Number of subjects: 622
Study 21342016 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal knowledge about infant health benefits; comfort with breastfeeding in social settings
Number of subjects: 883
Study 21342016 — intervention group
Group type: EXPERIMENTAL
Intervention: Disagreement with the statement 'Infant formula is as good as breastmilk'
Number of subjects: 883
Study 21342016 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement that breastfed infants were less likely to develop ear infections, respiratory infections, diarrhea, and obesity
Number of subjects: 883
Study 21342016 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfort breastfeeding in public
Number of subjects: 883
Study 19390480 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.7 g omega-3 LCPUFA supplementation
Number of subjects: 145
Study 19390480 — intervention group
Group type: COMPARATOR
Intervention: 2.8 g soybean oil as placebo
Number of subjects: 145
Study 16489946 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser (ERL1: 100 mJ; ERL2: 120 mJ; ERL3: 140 mJ; 10 Hz)
Number of subjects: 12
Study 16489946 — intervention group
Group type: EXPERIMENTAL
Intervention: Vector ultrasonic system (VUS)
Number of subjects: 12
Study 16489946 — intervention group
Group type: COMPARATOR
Intervention: Hand instruments (SRP)
Number of subjects: 12
Study 16489946 — intervention group
Group type: COMPARATOR
Intervention: Untreated teeth (Control)
Number of subjects: 12
Study 15324779 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid receptor binding in patients with CNP
Number of subjects: 0
Study 15324779 — intervention group
Group type: COMPARATOR
Intervention: Age-matched pain-free controls
Number of subjects: 0
Study 11387274 — intervention group
Group type: EXPERIMENTAL
Intervention: Normegon (25:75 IU/ampoule of LH and FSH)
Number of subjects: 27
Study 11387274 — intervention group
Group type: COMPARATOR
Intervention: rFSH (75 IU/ampoule of FSH alone)
Number of subjects: 27
Study 11387274 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 27
Study 9418687 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg)
Number of subjects: 40
Study 9418687 — intervention group
Group type: COMPARATOR
Intervention: Spironolactone (100 mg)
Number of subjects: 40
Study 8983932 — intervention group
Group type: EXPERIMENTAL
Intervention: Droxicam alone (20 mg)
Number of subjects: 12
Study 8983932 — intervention group
Group type: COMPARATOR
Intervention: Droxicam with antacid (Mucal powder)
Number of subjects: 12
Study 2921100 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 100 mg
Number of subjects: 15
Study 2921100 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (long-term treatment)
Number of subjects: 15
Study 30470978 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse Navigation Program
Number of subjects: 110
Study 30470978 — intervention group
Group type: COMPARATOR
Intervention: Usual care (non-navigated)
Number of subjects: 110
Study 30948288 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen
Number of subjects: 154
Study 30948288 — intervention group
Group type: COMPARATOR
Intervention: Oral acetaminophen
Number of subjects: 154
Study 27663600 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib 200 mg twice daily + carboplatin AUC4
Number of subjects: 77
Study 27663600 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib 100 or 200 mg twice daily (days 1-7) + carboplatin AUC4 or 5 every 21 days
Number of subjects: 77
Study 27663600 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib with carboplatin
Number of subjects: 77
Study 25503053 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette awareness
Number of subjects: 944
Study 25503053 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette use
Number of subjects: 944
Study 25503053 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette use trend
Number of subjects: 944
Study 25503053 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette advertisement exposure trend
Number of subjects: 944
Study 25503053 — intervention group
Group type: COMPARATOR
Intervention: Advertisement exposure comparison
Number of subjects: 944
Study 25503053 — intervention group
Group type: EXPERIMENTAL
Intervention: Advertisement exposure association
Number of subjects: 944
Study 24077548 — intervention group
Group type: EXPERIMENTAL
Intervention: biperiden (akineton)
Number of subjects: 35
Study 24077548 — intervention group
Group type: COMPARATOR
Intervention: trihexyphenidyl
Number of subjects: 35
Study 21601250 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 90
Study 21601250 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 90
Study 21601250 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (Control)
Number of subjects: 90
Study 19483074 — intervention group
Group type: EXPERIMENTAL
Intervention: poly‐L‐lactic acid polymer tack implants
Number of subjects: 40
Study 19483074 — intervention group
Group type: COMPARATOR
Intervention: polygluconate‐B polymer tack implants
Number of subjects: 40
Study 19483074 — intervention group
Group type: EXPERIMENTAL
Intervention: both implant types
Number of subjects: 40
Study 16508932 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX plus infliximab (3 mg/kg or 6 mg/kg)
Number of subjects: 0
Study 16508932 — intervention group
Group type: COMPARATOR
Intervention: MTX plus placebo
Number of subjects: 0
Study 16508932 — intervention group
Group type: COMPARATOR
Intervention: MTX alone
Number of subjects: 0
Study 12956498 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-welded titanium framework
Number of subjects: 42
Study 12956498 — intervention group
Group type: COMPARATOR
Intervention: Conventional cast framework
Number of subjects: 42
Study 12956498 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium framework prosthesis
Number of subjects: 42
Study 11079278 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 22
Study 11079278 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol plus glucagon 1 mg
Number of subjects: 22
Study 11079278 — intervention group
Group type: COMPARATOR
Intervention: Control (no therapy)
Number of subjects: 22
Study 9522324 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17‐β‐estradiol (50 μg/day)
Number of subjects: 9
Study 8322374 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 140
Study 8322374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 8322374 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac arrest
Number of subjects: 140
Study 8322374 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related atrophy
Number of subjects: 140
Study 3108007 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline plus naloxone (40 micrograms kg‐1 h‐1)
Number of subjects: 8
Study 3108007 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 8
Study 29509929 — intervention group
Group type: EXPERIMENTAL
Intervention: RSVcps2 (105.3 PFU, intranasal)
Number of subjects: 50
Study 29509929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 29084312 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation and financial incentives for smoking cessation (up to 4 hours of navigation over 6 months)
Number of subjects: 352
Study 29084312 — intervention group
Group type: COMPARATOR
Intervention: Control group (enhancement of usual care)
Number of subjects: 352
Study 29084312 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis for older participants (intervention)
Number of subjects: 352
Study 29084312 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis for women (intervention)
Number of subjects: 352
Study 29084312 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis for participants with household income of $20000 or less (intervention)
Number of subjects: 352
Study 29084312 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis for nonwhite participants (intervention)
Number of subjects: 352
Study 26125705 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhikang capsule in addition to conventional dressing changes
Number of subjects: 98
Study 26125705 — intervention group
Group type: COMPARATOR
Intervention: Regular dressing changes (observation group)
Number of subjects: 98
Study 23418154 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent exercise (INT) - 12 hourly, 5-min bouts
Number of subjects: 11
Study 23418154 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous exercise (EX) - 1-h exercise
Number of subjects: 11
Study 23418154 — intervention group
Group type: COMPARATOR
Intervention: Sedentary behavior (SED) - control condition
Number of subjects: 11
Study 21438717 — intervention group
Group type: EXPERIMENTAL
Intervention: VR‐I (conventional VR setup)
Number of subjects: 50
Study 21438717 — intervention group
Group type: EXPERIMENTAL
Intervention: VR‐II (VR environment with additional kinematic interaction)
Number of subjects: 50
Study 21438717 — intervention group
Group type: EXPERIMENTAL
Intervention: Box‐I (box trainer equivalent of VR‐I)
Number of subjects: 50
Study 21438717 — intervention group
Group type: EXPERIMENTAL
Intervention: Box‐II (box trainer equivalent of VR‐II)
Number of subjects: 50
Study 21438717 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 18376181 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGBP)
Number of subjects: 32
Study 18376181 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 32
Study 16755339 — intervention group
Group type: EXPERIMENTAL
Intervention: VDD(R) Saphir 3 device with nondedicated leads (Group 1)
Number of subjects: 45
Study 16755339 — intervention group
Group type: COMPARATOR
Intervention: VDD(R) Saphir 3 device with dedicated leads (Group 2)
Number of subjects: 45
Study 14585524 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/day
Number of subjects: 75
Study 14585524 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol Hemihidrate 2 mg + Norethindron Asetate 1 mg/day
Number of subjects: 75
Study 14585524 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta-estradiol 2 mg/day
Number of subjects: 75
Study 14585524 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-therapy values)
Number of subjects: 75
Study 10826420 — intervention group
Group type: EXPERIMENTAL
Intervention: W-pouch
Number of subjects: 24
Study 10826420 — intervention group
Group type: COMPARATOR
Intervention: J-pouch
Number of subjects: 24
Study 8852738 — intervention group
Group type: EXPERIMENTAL
Intervention: Blunt needle (HR48PP = protect point)
Number of subjects: 100
Study 8852738 — intervention group
Group type: COMPARATOR
Intervention: Sharp needle (HR48)
Number of subjects: 100
Study 1627981 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 0
Study 1627981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6442055 — intervention group
Group type: EXPERIMENTAL
Intervention: Auranofin (Ridaura)
Number of subjects: 121
Study 6442055 — intervention group
Group type: COMPARATOR
Intervention: Na-auro-thiomalate (Tauredon)
Number of subjects: 121
Study 6442055 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 121
Study 30610067 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-to-target approach
Number of subjects: 320
Study 30610067 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 320
Study 29396509 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep deprivation driving session
Number of subjects: 9
Study 29396509 — intervention group
Group type: COMPARATOR
Intervention: Normal sleep driving session
Number of subjects: 9
Study 27460108 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised herbs prescribed by a Chinese herbal practitioner
Number of subjects: 80
Study 27460108 — intervention group
Group type: COMPARATOR
Intervention: Standardised herbs provided by primary care clinicians
Number of subjects: 80
Study 27460108 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (individualised and standardised herbs)
Number of subjects: 80
Study 24320728 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine
Number of subjects: 70
Study 24320728 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine
Number of subjects: 70
Study 22825293 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent sterile dressing
Number of subjects: 703
Study 22825293 — intervention group
Group type: COMPARATOR
Intervention: Standard dressing (non sterile sticking plaster)
Number of subjects: 703
Study 19320546 — intervention group
Group type: EXPERIMENTAL
Intervention: Rostrolateral prefrontal cortex (RLPFC) activation during relational integration trials
Number of subjects: 0
Study 19320546 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampus activation during relational encoding trials
Number of subjects: 0
Study 18044285 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative music (Spanish guitar)
Number of subjects: 100
Study 18044285 — intervention group
Group type: COMPARATOR
Intervention: Control group (white noise)
Number of subjects: 100
Study 15695500 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine-mitoxantrone (FM)
Number of subjects: 155
Study 15695500 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP)
Number of subjects: 155
Study 11872997 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.95% THC marijuana cigarettes
Number of subjects: 62
Study 11872997 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol 2.5 mg capsules
Number of subjects: 62
Study 11872997 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 62
Study 10194038 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tacrolimus followed by oral therapy and mycophenolate mofetil (MMF) with a fixed dose of 2 g/day in Phase I and adjusted doses in Phase II based on mycophenolic acid (MPA) plasma levels.
Number of subjects: 45
Study 7566846 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative laparoscopy
Number of subjects: 40
Study 7566846 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 40
Study 2109639 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 17
Study 7375940 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0
Study 7375940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31932567 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium intervention (not specified in detail)
Number of subjects: 1000
Study 31932567 — intervention group
Group type: COMPARATOR
Intervention: Risk factors affecting delirium (e.g., age over 65, unconsciousness, dependent activities, abnormal vital signs, pressure ulcer risk, enteral nutrition, use of restraint)
Number of subjects: 1000
Study 28325532 — intervention group
Group type: EXPERIMENTAL
Intervention: Binaural beats (200Hz for left ear and 209.3Hz for right ear)
Number of subjects: 60
Study 28325532 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study 25527053 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal indomethacin
Number of subjects: 577
Study 25527053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 577
Study 25527053 — intervention group
Group type: COMPARATOR
Intervention: Successful stent placement
Number of subjects: 577
Study 25527053 — intervention group
Group type: COMPARATOR
Intervention: No stent attempt
Number of subjects: 577
Study 23653274 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg fasting and 5 mg at bedtime)
Number of subjects: 80
Study 23653274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 23964473 — intervention group
Group type: EXPERIMENTAL
Intervention: St. John's Wort extract WS 5570, 600 mg once daily for 8 to 10 weeks
Number of subjects: 1300
Study 23964473 — intervention group
Group type: COMPARATOR
Intervention: St. John's Wort extract WS 5570, 600 mg once daily
Number of subjects: 1300
Study 20046574 — intervention group
Group type: EXPERIMENTAL
Intervention: huCD25mAb
Number of subjects: 15
Study 20046574 — intervention group
Group type: COMPARATOR
Intervention: daclizumab
Number of subjects: 15
Study 17287448 — intervention group
Group type: EXPERIMENTAL
Intervention: APOE4 status, Symbol Digit Modalities Test, Delayed 10‐Word List Recall, New York University Paragraph Recall Test (Delayed), ADAS‐cog total score
Number of subjects: 539
Study 17287448 — intervention group
Group type: EXPERIMENTAL
Intervention: APOE4 status removed from analysis
Number of subjects: 539
Study 15051210 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal aberrations measured at various time intervals after a blink (0, 10, and 20 seconds)
Number of subjects: 20
Study 15051210 — intervention group
Group type: EXPERIMENTAL
Intervention: Total ocular aberrations measured at various time intervals after a blink (0, 10, and 20 seconds)
Number of subjects: 20
Study 15051210 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical quality metric (Mf) measured after a blink
Number of subjects: 20
Study 11903211 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured one-to-one education
Number of subjects: 160
Study 11903211 — intervention group
Group type: COMPARATOR
Intervention: Usual postpartum care
Number of subjects: 160
Study 9550241 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled intermittent hospitalization (four hospital admissions lasting nine to 11 days each, per year for two years)
Number of subjects: 57
Study 9550241 — intervention group
Group type: COMPARATOR
Intervention: Traditional access to hospital care
Number of subjects: 57